Patrick A. Flume

Patrick A. Flume

Intensive Care Medicine | Pulmonary Medicine
171 Ashley Ave
Charleston, SC 29425

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 204 publications

From the editor's desk.

From the editor's desk.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: May 16, 2026

Forced vital capacity in pulmonary exacerbations of cystic fibrosis.

Forced vital capacity in pulmonary exacerbations of cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: April 11, 2026

From the editor's desk.

From the editor's desk.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: March 13, 2026

Obesity in adults with cystic fibrosis following prescription of elexacaftor/tezacaftor/ivacaftor.

Obesity in adults with cystic fibrosis following prescription of elexacaftor/tezacaftor/ivacaftor.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: February 04, 2026

Cystic fibrosis care utilization from 2019-2023: a descriptive analysis of adult and pediatric CF care utilization in the post-ETI and post-pandemic Era.

Cystic fibrosis care utilization from 2019-2023: a descriptive analysis of adult and pediatric CF care utilization in the post-ETI and post-pandemic Era.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: January 30, 2026

Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?

Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?

Journal: The European respiratory journal
Published: January 03, 2026

Does it matter how cystic fibrosis transmembrane conductance regulator modulators reduce inflammation in cystic fibrosis?

Does it matter how cystic fibrosis transmembrane conductance regulator modulators reduce inflammation in cystic fibrosis?

Journal: Annals of the American Thoracic Society
Published: December 02, 2025

Patient-reported outcome measures developed for non-cystic fibrosis bronchiectasis may be applied to cystic fibrosis bronchiectasis.

Patient-reported outcome measures developed for non-cystic fibrosis bronchiectasis may be applied to cystic fibrosis bronchiectasis.

Journal: Health and quality of life outcomes
Published: November 13, 2025

Integration of psychological care into a nontuberculous mycobacteria (NTM) program in the Southeastern United States: A retrospective cohort study.

Integration of psychological care into a nontuberculous mycobacteria (NTM) program in the Southeastern United States: A retrospective cohort study.

Journal: Therapeutic advances in respiratory disease
Published: November 12, 2025

Structure of a Bronchiectasis and Nontuberculous Mycobacteria Care Center: A Position Statement by the Bronchiectasis & NTM Association.

Structure of a Bronchiectasis and Nontuberculous Mycobacteria Care Center: A Position Statement by the Bronchiectasis & NTM Association.

Journal: Chest
Published: September 26, 2025

Evaluating the association of antibiotic spectrum and treatment responses of cystic fibrosis pulmonary exacerbations.

Evaluating the association of antibiotic spectrum and treatment responses of cystic fibrosis pulmonary exacerbations.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: September 22, 2025

The impact of dornase alfa on imaging features of bronchiectasis.

The impact of dornase alfa on imaging features of bronchiectasis.

Journal: Research square
Published: September 15, 2025
Showing 1-12 of 204

Last Updated: 09/26/2026